[{"from": "human", "value": "Could you give me a brief overview of this molecule? [C][C@H1][C][C@H1][C@@H1][C][C][C@@][Branch2][Ring1][P][C@][Ring1][Branch1][Branch2][Ring1][#Branch2][C][C@@H1][Branch2][Ring1][Ring2][C@@H1][Ring1][=Branch2][C@@][Branch1][=N][C][Ring1][=N][=C][C][=Branch1][C][=O][C][=C][Ring1][#Branch1][C][O][C][Branch1][#Branch1][C][=Branch1][C][=O][C][O][O]"}, {"from": "gpt", "value": "The molecule is a [prednisolone] derivative glucocorticoid with higher potency than [prednisone]. It was first described in the literature in the late 1950s.  Methylprednisolone was granted FDA approval on 24 October 1957. In the outbreak of COVID-19, low dose methylprednisolone-based therapy was successful in treating COVID-19-associated pneumonia in one patient with long-term immunosuppression. The efficacy of methylprednisolone in novel coronavirus pneumonia is being investigated further in clinical trials."}]